ATE184788T1 - Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer - Google Patents

Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer

Info

Publication number
ATE184788T1
ATE184788T1 AT94303847T AT94303847T ATE184788T1 AT E184788 T1 ATE184788 T1 AT E184788T1 AT 94303847 T AT94303847 T AT 94303847T AT 94303847 T AT94303847 T AT 94303847T AT E184788 T1 ATE184788 T1 AT E184788T1
Authority
AT
Austria
Prior art keywords
alzheimer
treatment
compositions containing
idebenone
containing idebenone
Prior art date
Application number
AT94303847T
Other languages
English (en)
Inventor
Masaomi Miyamoto
Akinobu Nagaoka
Giichi Goto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE184788T1 publication Critical patent/ATE184788T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94303847T 1993-06-18 1994-05-27 Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer ATE184788T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14815493 1993-06-18

Publications (1)

Publication Number Publication Date
ATE184788T1 true ATE184788T1 (de) 1999-10-15

Family

ID=15446472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94303847T ATE184788T1 (de) 1993-06-18 1994-05-27 Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer

Country Status (8)

Country Link
EP (1) EP0629400B1 (de)
JP (1) JPH0761923A (de)
AT (1) ATE184788T1 (de)
CA (1) CA2125822A1 (de)
DE (1) DE69420776T2 (de)
DK (1) DK0629400T3 (de)
ES (1) ES2136167T3 (de)
GR (1) GR3032041T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549262C2 (de) * 1995-02-08 1997-10-09 Martin Dr Kohlmeier Präparat zur Abschätzung des Entstehungsrisikos eines beschleunigten Verlustes kognitiver Fähigkeiten
EP0788793A1 (de) 1996-02-01 1997-08-13 Takeda Chemical Industries, Ltd. Idebenon zur Behandlung von Demenz
CA2252519A1 (en) * 1996-07-11 1998-01-22 Keisuke Hirai Use of idebenone and analogues against beta amyloid induced cytotoxicity
EP0952826B1 (de) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung
US5962535A (en) * 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
WO1999007355A1 (fr) * 1997-08-12 1999-02-18 Takeda Chemical Industries, Ltd. Preparation contenant de l'idebenone pour administration par voie percutanee
JP2003226639A (ja) * 2002-01-31 2003-08-12 Hisamitsu Pharmaceut Co Inc 神経成長因子活性増強剤としてのビタミンｋ類を含む医薬組成物およびその使用
AR055453A1 (es) * 2004-01-06 2007-08-22 Creactivar S A Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende
PL1888059T3 (pl) 2005-06-01 2015-06-30 Bioelectron Tech Corp Środki terapeutyczne aktywne wobec układów redoks do leczenia chorób mitochondrialnych i innych zaburzeń oraz modulacja biomarkerów energetycznych
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
MX2011002318A (es) 2008-09-10 2011-05-10 Edison Pharmaceuticals Inc Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
WO2014035356A1 (en) * 2012-08-31 2014-03-06 Mahmut Bilgic Tablet formulations comprising a quinone derivative active agent
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
EP4351545A1 (de) 2021-06-07 2024-04-17 Katholieke Universiteit Leuven Idebenon zur behandlung von arzneimittelresistenter epilepsie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08768B2 (ja) * 1989-08-24 1996-01-10 武田薬品工業株式会社 神経成長因子分泌誘導剤

Also Published As

Publication number Publication date
CA2125822A1 (en) 1994-12-19
EP0629400B1 (de) 1999-09-22
JPH0761923A (ja) 1995-03-07
DE69420776D1 (de) 1999-10-28
EP0629400A1 (de) 1994-12-21
ES2136167T3 (es) 1999-11-16
GR3032041T3 (en) 2000-03-31
DE69420776T2 (de) 2000-05-18
DK0629400T3 (da) 2000-02-14

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69420776D1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE3774361D1 (de) Verwendung von usninsaeure oder deren derivaten bei der behandlung von zahnfaeule.
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
CA2279184A1 (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
KR890004705A (ko) 항바이러스성 제제
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
DE69315162T2 (de) Verwendung von L-Carnitine und Acyl-L-Carnitinen zur Behandlung von Patienten die an AIDS-verwandten Syndromen leiden und von asymptomatischen HIV-seropositiven Patienten
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
NO952912L (no) En ny osteoblastisk proliferativ faktor
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
DE69131521D1 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
HK1021685A1 (en) Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee